| Description |
1 online resource (streaming video file) (629 secs.) |
| Series |
Immunology and Infection |
| Summary |
New models and assays that would improve the early drug development process for next-generation anti-tuberculosis drugs are highly desirable. Here, we describe a quick, inexpensive, and BSL-2 compatible assay to evaluate drug efficacy against Mycobacterium tuberculosis that can be easily adapted for high-throughput screening |
| Audience |
For undergraduate, graduate, and professional students |
| Notes |
English |
|
Description based on online resource; title from resource description page |
| Subject |
Immunology and Infection
|
| Form |
Streaming audio
|
|
